Table 2.
Allowed Per-Patient Per-Month Cost of CKD
| CKD severity stage | Medicare allowed PPPM cost, $ | Commercial allowed PPPM cost, $ | ||
|---|---|---|---|---|
| with hyperkalemia | without hyperkalemia | with hyperkalemia | without hyperkalemia | |
| Stage I | 4896 | 1509 | 5544 | 1508 |
| Stage II | 4571 | 1513 | 6052 | 1696 |
| Stage III | 4552 | 1842 | 6658 | 2488 |
| Stage IV | 5043 | 2525 | 6843 | 3703 |
| Stage V | 5491 | 2819 | 6442 | 3392 |
| Unknown stage | 5803 | 2450 | 11,332 | 3395 |
| All patients with CKDa | 4945 | 2137 | 7247 | 2879 |
PPPM cost in the hyperkalemia and nonhyperkalemia populations after adjusting for CKD severity.
CKD indicates chronic kidney disease; PPPM, per-patient per-month.
Source: Milliman's analysis of 2014 Medicare 5% sample data and MarketScan medical claims data.